| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0026 | 1 |